Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting, has a long half-life allowing ... associated with few drug interactions other ...

Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.

We extend our heartfelt thanks to everyone who supported our vision for a world where HIV is no longer a threat to health ... It is estimated that the ‘half-life’ (how long it takes for the drug ...

Drug abuse and peer pressure are major threats to our communities, particularly the youths, says Deputy Prime Minister and Minister for Trade, Manoa Kamikamica.

The UN Development Programme (UNDP) has delivered 3000 antiretroviral drugs to Fiji to support the HIV ... Health and Medical Services to ensure critical HIV services remain uninterrupted. "Access to ...

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...

Antimicrobial resistance (AMR) poses a critical public health threat, with gendered implications that are often overlooked.

One shocking example of such exploitation is the practice of wife rental, which has persisted for decades in Madhya Pradesh, ...

Had Jackson Browne an American president in mind when he musically asked in 1977, "Are you there for the pretender?" 77 million American voters answered almost 50 years later, "Yes." On 20 January ...

Had Jackson Browne an American president in mind when he musically asked in 1977, "Are you there for the pretender?" 77 million American voters answered almost 50 years later, "Yes." On 20 January ...

In 1998, a pharmaceutical company suddenly lost the ability to make their lifesaving HIV drug at one of its production facilities. Then that failure spread to the company’s analy ...

Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...